Carl Icahn claims Illumina directors got extra insurance to close ‘disastrous’ $7.1…
Carl Icahn on Friday alleged that Illumina's directors demanded extra personal liability insurance before the biotech company signed off on a $7.1 billion acquisition of cancer test developer Grail in 2021. The claim is the latest…